Medistim ASA
MEDI
Rank in Stocks
#10988
Medistim ASA develops, produces, services, leases, and distributes medical... Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Share Price
$33.93
Last synced: 2026-11-09
Market Cap
$620.29M
Change (1 day)
4.90%
Change (1 year)
37.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medistim ASA (MEDI)
Category
Healthcare
EPS for Medistim ASA (MEDI)
EPS as of September 2026 TTM: $1.05
According to Medistim ASA's latest financial reports, its current EPS (TTM) is $1.05. At the end of 2025 the company had an EPS of $0.86, an increase over its 2024 EPS of $0.50.
EPS history for Medistim ASA from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.05 | 22.37% |
| 2025 | $0.86 | 72.58% |
| 2024 | $0.50 | -10.23% |
| 2023 | $0.56 | -12.87% |
| 2022 | $0.64 | 13.02% |
| 2021 | $0.57 | 28.29% |
| 2020 | $0.44 | -1.39% |
| 2019 | $0.45 | 21.25% |
| 2018 | $0.37 | 15.57% |
| 2017 | $0.32 | 28.24% |
| 2016 | $0.25 | -1.39% |
| 2015 | $0.25 | 8.79% |
| 2014 | $0.23 | -4.05% |
| 2013 | $0.24 | -18.91% |
| 2012 | $0.30 | 110.00% |
| 2011 | $0.14 | -18.76% |
| 2010 | $0.17 | -33.15% |
| 2009 | $0.26 | 140.35% |
| 2008 | $0.11 | -60.96% |
| 2007 | $0.28 | 83.11% |
| 2006 | $0.15 | 63.30% |
| 2005 | $0.09 | 20.10% |
| 2004 | $0.08 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | 156.56% |
US
|
|
| $4.09 | 288.64% |
IE
|
|
| $9.45 | 797.95% |
US
|
|
| $2.37 | 125.20% |
US
|
|
| $1.77 | 68.19% |
US
|
Questions about Medistim ASA's earnings per share (EPS)
What is Medistim ASA's earnings per share (EPS)?
Medistim ASA's earnings per share (EPS) over the last twelve months is $1.05, as of Sep 2026.
What was Medistim ASA's earnings per share (EPS) in 2025?
In 2025, Medistim ASA's earnings per share (EPS) was $0.86, 72.00% more than in 2024 ($0.50).
How has Medistim ASA's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Medistim ASA's earnings per share (EPS) went from $0.44 to $0.86, an average growth of 14.34% a year.
How does Medistim ASA's earnings per share (EPS) compare with similar companies?
Medistim ASA's earnings per share (EPS) ($1.05) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.